Small study suggests 40Hz sensory stimulation may benefit some Alzheimer’s patients for years October 27, 2025 … clinical trial run by MIT-spinoff company Cognito Therapeutics. “This pilot study assessed the long-term …
Pew award will fund study of neural role in respiratory disease June 18, 2024 … Prescott said. “Our hope is to use these insights to build therapeutics that could halt or reverse airway scarring, or …
Aging Brain Initiative symposium showcases ‘cutting edge’ research across MIT November 01, 2023 … metabolomics in neurodegenerative diseases, to potential therapeutics, such as gene therapies, or sensory stimulation …
Small studies of 40Hz sensory stimulation confirm safety, suggest Alzheimer’s benefits December 01, 2022 … for Parkinson’s disease and Down syndrome. Cognito Therapeutics, an MIT spin-off company co-founded by Tsai and …
Alumnus gives MIT $4.5 million to establish the Broderick Fund for Phytocannabinoid Research April 30, 2019
